Kexing Biopharm Co., Ltd.SSE: 688136

SHAN DONG KEXING BIOPRODUCTS CO., LTD.: Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

· Issued by Kexing Biopharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE ·

On 6ix: 6ix.com/news/shan-dong-kexing-bioproducts-co-ltdannouncement-on-participating-in-the-2026-semi-annual-collective-performance-briefing-for-the-star-market-innovative-drug-industry

Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Kexing Biopharm Co., Ltd. on 6ix

Story so far

Earlier from Kexing Biopharm

Later from Kexing Biopharm

All Kexing Biopharm news releases